This year our team will continue to work with Mochida Pharmaceutical Ltd. to explore further indications for alginate-based technologies, with projects focused on #tendon protection, #cavernous nerve repair and #cartilage treatment on the horizon.
The product pipeline is exciting and our vision is clear – to develop #innovative medical technologies to enhance the wellbeing of patients globally.
Pictured are Hitoshi Mizuno – Executive Managing Officer, Head of Biomaterials Business Division at Mochida Pharmaceutical; Gerard Insley – Chief Science Officer at PBC Biomed; Pierse Danaher -Finance Director at PBC Biomed; and Akihisa Iwabuchi – Associate Manager, Medical Device Quality Management and Regulatory Affairs at Mochida Pharmaceutical Ltd, on a recent trip to the Mochida Headquarters in Tokyo, Japan.
#partnership #productpipeline #acceleratingmedicalinnovation #alginate
